Senior insider sale
Chief Legal Officer at IRONWOOD PHARMACEUTICALS INC — senior position signals high conviction
$154.6K
33.53K shares
JOHN MINARDO plans to sell 33.53K shares of IRONWOOD PHARMACEUTICALS INC valued at approximately $154.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan, subject to vesting requirements
N/A
Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan, subject to vesting requirements
N/A
Restricted Stock Unit award granted pursuant to the Issuer's 2019 Equity Incentive Plan, subject to vesting requirements
N/A
Restricted Stock Unit award granted pursuant to the Issuer's 2019 Equity Incentive Plan, subject to vesting requirements
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/10/2025 | Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan, subject to vesting requirements N/A | 30.56K | — |
2/12/2024 | Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan, subject to vesting requirements N/A | 13.61K | — |
3/8/2023 | Restricted Stock Unit award granted pursuant to the Issuer's 2019 Equity Incentive Plan, subject to vesting requirements N/A | 16.38K | — |
3/2/2022 | Restricted Stock Unit award granted pursuant to the Issuer's 2019 Equity Incentive Plan, subject to vesting requirements N/A | 16.97K | — |
| Total | 77.51K | ||
Units to sell
33.53K
Market value
$154.6K
Units
33.53K
Value
$154.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/23/2026 | 33.53K | $154.6K | Nasdaq | Planned |
| Total | 33.53K | $154.6K | ||